From Culture to Sequencing: Evolving Strategies for the Diagnosis of Pediatric Spondylodiscitis

Abstract

Pediatric spondylodiscitis is a rare but clinically significant infection affecting the intervertebral disc and adjacent vertebral bodies. Diagnostic delays are common due to its nonspecific presentation and the limited sensitivity of conventional microbiological methods. Early and accurate pathogen identification is essential to guide antimicrobial therapy, minimize unnecessary invasive procedures, and prevent long-term sequelae. Traditional diagnostic tools—including laboratory tests, imaging, blood cultures, biopsy, and histopathological evaluation—remain fundamental but are often insufficient, as they may yield nonspecific results or culture-negative cases, particularly after prior antibiotic exposure or infection with fastidious organisms. In recent years, molecular approaches, ranging from polymerase chain reaction assays to metagenomic next-generation sequencing, have markedly improved diagnostic accuracy. These techniques allow rapid and comprehensive pathogen detection, including atypical or previously uncultivable organisms, thereby overcoming many limitations of conventional methods. This narrative review synthesizes current evidence on pediatric spondylodiscitis, outlining its epidemiology, clinical features, and the evolving spectrum of diagnostic strategies—from conventional methods to advanced molecular and sequencing-based technologies—while discussing future directions in this challenging field.

Keywords

diagnosis / narrative review / pediatric / spine / spondylodiscitis

References

[1] L. S. Al Yazidi, H. Hameed, A. Kesson, and D. Isaacs, “Spondylodiscitis in Children,” Journal of Paediatrics and Child Health 58 (2022): 1731–1735, https://doi.org/10.1111/JPC.16175.

[2] S. Bianchini, A. Esposito, N. Principi, and S. Esposito, “Spondylodiscitis in Paediatric Patients: The Importance of Early Diagnosis and Prolonged Therapy,” International Journal of Environmental Research and Public Health 15 (2018): 1195, https://doi.org/10.3390/IJERPH15061195.

[3] L. Gentile, F. Benazzo, F. de Rosa, et al., “A Systematic Review: Characteristics, Complications and Treatment of Spondylodiscitis,” European Review for Medical and Pharmacological Sciences 23 (2019): 117–128, https://doi.org/10.26355/EURREV_201904_17481.

[4] D. G. Taylor, A. L. Buchholz, D. R. Sure, et al., “Presentation and Outcomes After Medical and Surgical Treatment Versus Medical Treatment Alone of Spontaneous Infectious Spondylodiscitis: A Systematic Literature Review and Meta-Analysis,” Global Spine Journal 8 (2018): 49S–58S, https://doi.org/10.1177/2192568218799058.

[5] E. S. Saleh, C. C. Vasileff, A. M. Omari, et al., “The Diagnosis and Management of Pediatric Spine Infections,” Cureus 13, no. 7 (2021): e16748, https://doi.org/10.7759/cureus.16748.

[6] N. Lashkarbolouk, M. Mazandarani, B. Ilharreborde, and M. H. Nabian, “Understanding the Management of Pediatric Spondylodiscitis Based on Existing Literature: A Systematic Review,” BMC Pediatrics 23, no. 1 (2023): 578, https://doi.org/10.1186/S12887-023-04395-2.

[7] A. G. Tsantes, D. V. Papadopoulos, G. Vrioni, et al., “Spinal Infections: An Update,” Microorganisms 8, no. 4 (2020): 476, https://doi.org/10.3390/microorganisms8040476.

[8] R. Dayer, G. De Marco, O. Vazquez, et al., “Laboratory Diagnostics for Primary Spinal Infections in Pediatric and Adult Populations: A Narrative Review,” North American Spine Society Journal (NASSJ) 16 (2023): 100270, https://doi.org/10.1016/J.XNSJ.2023.100270.

[9] O. Avanzi, Y. C. Lin, R. Meves, and C. Mattos, “Tratamento da Discite na Criança,” Revista Da Associacao Medica Brasileira 51 (2005): 113–116, https://doi.org/10.1590/S0104-42302005000200019.

[10] R. Kayser, K. Mahlfeld, M. Greulich, and H. Grasshoff, “Spondylodiscitis in Childhood: Results of a Long-Term Study,” Spine 30 (2005): 318–323, https://doi.org/10.1097/01.BRS.0000152097.57891.98.

[11] P. M. De Moraes Barros Fucs, R. Meves, and H. H. Yamada, “Spinal Infections in Children: A Review,” International Orthopaedics 36 (2012): 387–395.

[12] E. Garron, E. Viehweger, F. Launay, J. M. Guillaume, J. L. Jouve, and G. Bollini, “Nontuberculous Spondylodiscitis in Children,” Journal of Pediatric Orthopaedics 22 (2002): 321–328.

[13] R. Dayer, M. M. Alzahrani, N. Saran, et al., “Spinal Infections in Children: A Multicentre Retrospective Study,” Bone and Joint Journal. British Editorial Society of Bone and Joint Surgery 100 (2018): 542–548, https://doi.org/10.1302/0301-620X.100B4.BJJ-2017-1080.R1/LETTERTOEDITOR.

[14] S. Cavalieri, B. Pessina, G. Indolfi, L. Galli, and S. Trapani, “Spondylodiscitis in Pediatric Age: A Retrospective Cohort Study,” Pediatric Infectious Disease Journal 41 (2022): 530–536, https://doi.org/10.1097/INF.0000000000003534.

[15] R. Sobottke, H. Seifert, G. Fätkenheuer, M. Schmidt, A. Goßmann, and P. Eysel, “Current Diagnosis and Treatment of Spondylodiscitis,” Deutsches Ärzteblatt International 105 (2008): 181–187, https://doi.org/10.3238/ARZTEBL.2008.0181.

[16] G. S. Skaf, N. T. Domloj, M. G. Fehlings, et al., “Pyogenic Spondylodiscitis: An Overview,” Journal of Infection and Public Health 3 (2010): 5–16, https://doi.org/10.1016/J.JIPH.2010.01.001.

[17] S. D. Early, R. M. Kay, and V. T. Tolo, “Childhood Diskitis,” Journal of the American Academy of Orthopaedic Surgeons 11 (2003): 413–420.

[18] H. M. Kang, E. H. Choi, H. J. Lee, et al., “The Etiology, Clinical Presentation and Long-Term Outcome of Spondylodiscitis in Children,” Pediatric Infectious Disease Journal 35 (2016): e102–e106, https://doi.org/10.1097/INF.0000000000001043.

[19] C. J. Kim, K. H. Song, J. H. Jeon, et al., “A Comparative Study of Pyogenic and Tuberculous Spondylodiscitis,” Spine 35 (2010): 1096–1100, https://doi.org/10.1097/BRS.0B013E3181E04DD3.

[20] A. H. Cushing, “Diskitis in Children,” Clinical Infectious Diseases 17 (1993): 1–6, https://doi.org/10.1093/CLINIDS/17.1.1.

[21] L. Cottle and T. Riordan, “Infectious Spondylodiscitis,” Journal of Infection 56 (2008): 401–412, https://doi.org/10.1016/j.jinf.2008.02.005.

[22] R. Brown, M. Hussain, K. McHugh, V. Novelli, and D. Jones, “Discitis in Young Children,” Journal of Bone and Joint Surgery (British Volume) 83 (2001): 106–111, https://doi.org/10.1302/0301-620X.83B1.10865.

[23] B. B. Do Couto, R. S. G. Umeta, M. F. S. Caffaro, R. Meves, E. Landim, and O. Avanzi, “Análise Radiológica Comparativa Entre Espondilodiscite Tuberculosa e Inespecífica,” Coluna/Columna 9 (2010): 394–400, https://doi.org/10.1590/S1808-18512010000400009.

[24] K. R. Gabriel and A. H. Crawford, “Magnetic Resonance Imaging in a Child Who Had Clinical Signs of Discitis. Report of a Case,” Journal of Bone and Joint Surgery 70 (1988): 938–941.

[25] A. Mitha, N. Boutry, E. Nectoux, et al., “Community-Acquired Bone and Joint Infections in Children: A 1-Year Prospective Epidemiological Study,” Archives of Disease in Childhood 100 (2015): 126–129, https://doi.org/10.1136/ARCHDISCHILD-2013-305860.

[26] N. Ventura, E. Gonzalez, L. Terricabras, A. Salvador, and M. Cabrera, “Intervertebral Discitis in Children: A Review of 12 Cases,” International Orthopaedics 20 (1996): 32–34.

[27] Z. Karabouta, I. Bisbinas, A. Davidson, and L. L. Goldsworthy, “Discitis in Toddlers: A Case Series and Review,” Acta Paediatrica 94 (2005): 1516–1518, https://doi.org/10.1111/J.1651-2227.2005.TB01832.X.

[28] A. Stäbler and M. F. Reiser, “Imaging of Spinal Infection,” Radiologic Clinics of North America 39 (2001): 115–135, https://doi.org/10.1016/S0033-8389(05)70266-9.

[29] C. Smids, I. J. E. Kouijzer, F. J. Vos, et al., “A Comparison of the Diagnostic Value of MRI and 18F-FDG-PET/CT in Suspected Spondylodiscitis,” Infection 45, no. 1 (2016): 41–49, https://doi.org/10.1007/S15010-016-0914-Y.

[30] G. Kafle, B. Garg, N. Mehta, et al., “Diagnostic Yield of Image-Guided Biopsy in Patients With Suspected Infectious Spondylodiscitis: A Prospective Study From a Tuberculosis-Endemic Country,” Bone & Joint Journal 104, no. 1 (2022): 120–126, https://doi.org/10.1302/0301-620X.104B1.BJJ-2021-0848.R2.

[31] F. S. Chew and M. J. Kline, “Diagnostic Yield of CT-Guided Percutaneous Aspiration Procedures in Suspected Spontaneous Infectious Diskitis,” Internet 218 (2001): 211–214, https://doi.org/10.1148/RADIOLOGY.218.1.R01JA06211.

[32] R. C. A. Ravichandran, R. Amritanand, V. Moses, et al., “Computed Tomography-Guided Spinal Biopsy in Suspected Infective Spondylodiscitis: An Institutional Review of Its Utility,” Indian Journal of Radiology and Imaging 33 (2023): 289–294, https://doi.org/10.1055/S-0043-1764491/ID/JR2291933-18/BIB.

[33] S. C. A. Michel, C. W. A. Pfirrmann, N. Boos, J. Hodler, and American Roentgen Ray Society, “CT-Guided Core Biopsy of Subchondral Bone and Intervertebral Space in Suspected Spondylodiskitis,” American Journal of Roentgenology 186 (2006): 977–980, https://doi.org/10.2214/AJR.05.0109/ASSET/IMAGES/00_05_0109_02.JPEG.

[34] J. K. Sehn and L. A. Gilula, “Percutaneous Needle Biopsy in Diagnosis and Identification of Causative Organisms in Cases of Suspected Vertebral Osteomyelitis,” European Journal of Radiology 81 (2012): 940–946.

[35] C. Juchler, V. Spyropoulou, N. Wagner, et al., “The Contemporary Bacteriologic Epidemiology of Osteoarticular Infections in Children in Switzerland,” Journal of Pediatrics 194 (2018): 190–196.e1, https://doi.org/10.1016/j.jpeds.2017.11.025.

[36] B. Coulin, G. DeMarco, O. Vazquez, et al., “Osteoarticular Infections in Children: Accurately Distinguishing Between MSSA and Kingella kingae,” Microorganisms 11 (2022): 11, https://doi.org/10.3390/microorganisms11010011.

[37] E. Samara, V. Spyropoulou, A. Tabard-Fougère, et al., “Kingella Kingae and Osteoarticular Infections,” Pediatrics 144 (2019): e20191509, https://doi.org/10.1542/peds.2019-1509.

[38] K. Zhang, Y. Z. Bai, C. Liu, S. S. Liu, X. X. Lu, and R. G. Yang, “Composition of Pathogenic Microorganism in Chronic Osteomyelitis Based on Metagenomic Sequencing and Its Application Value in Etiological Diagnosis,” BMC Microbiology 23, no. 1 (2023): 313, https://doi.org/10.1186/s12866-023-03046-x.

[39] G. Yan, Z. Liu, T. Teng, et al., “Metagenomic Next-Generation Sequencing of Osteoarticular Tissue for the Diagnosis of Suspected Osteoarticular Tuberculosis,” Microbiology Spectrum 12 (2024): 12, https://doi.org/10.1128/spectrum.03598-23.

[40] Z. Tao, M. Zhu, J. Shi, Z. Yang, and N. K. Niu, “The Application Value of Targeted Next-Generation Sequencing in the Diagnosis of Primary Osteoarticular Infections: A Single-Center Study,” Frontiers in Cellular and Infection Microbiology 15 (2025): 1593228, https://doi.org/10.3389/FCIMB.2025.1593228/BIBTEX.

[41] Q. Zhang, Q. Wang, F. Zhang, et al., “Diagnostic Value of Metagenomic Next-Generation Sequencing in Patients With Osteoarticular Infections: A Prospective Study,” Frontiers in Cellular and Infection Microbiology 13 (2025): 13, https://doi.org/10.1128/spectrum.01064-24.

[42] Z. Da Huang, Z. J. Zhang, B. Yang, et al., “Pathogenic Detection by Metagenomic Next-Generation Sequencing in Osteoarticular Infections,” Frontiers in Cellular and Infection Microbiology 10 (2020): 550546, https://doi.org/10.3389/FCIMB.2020.00471/BIBTEX.

[43] A. Ferroni, H. Al Khoury, C. Dana, et al., “Prospective Survey of Acute Osteoarticular Infections in a French Paediatric Orthopedic Surgery Unit,” Clinical Microbiology and Infection 19 (2013): 822–828.

[44] N. Principi and S. Esposito, “Infectious Discitis and Spondylodiscitis in Children,” International Journal of Molecular Sciences 17, no. 4 (2016): 539, https://doi.org/10.3390/ijms17040539.

[45] D. Ceroni, M. Chargui, G. De Marco, C. Steiger, and R. Dayer, “Better Comprehension of Primary Pyogenic Spinal Infections,” Pediatric Infectious Disease Journal 42 (2023): E39–E40, https://doi.org/10.1097/INF.0000000000003745.

[46] A. C. Offiah, “Acute Osteomyelitis, Septic Arthritis and Discitis: Differences Between Neonates and Older Children,” European Journal of Radiology 60 (2006): 221–232, https://doi.org/10.1016/j.ejrad.2006.07.016.

[47] M. Al-Qwbani, N. Jiang, and B. Yu, “Kingella kingae-Associated Pediatric Osteoarticular Infections: An Overview of 566 Reported Cases,” Clinical Pediatrics 55 (2016): 1328–1337, https://doi.org/10.1177/0009922816629620.

[48] I. Ferri, G. Ristori, C. Lisi, L. Galli, and E. Chiappini, “Characteristics, Management and Outcomes of Spondylodiscitis in Children: A Systematic Review,” Antibiotics 10 (2021): 30, https://doi.org/10.3390/ANTIBIOTICS10010030.

[49] F. T. Afshari, D. Rodrigues, M. Bhat, G. A. Solanki, A. R. Walsh, and W. B. Lo, “Paediatric Spondylodiscitis: A 10-Year Single Institution Experience in Management and Clinical Outcomes,” Child's Nervous System 36, no. 5 (2019): 1049–1054, https://doi.org/10.1007/S00381-019-04470-Z.

[50] S. Ryoppy and J. Jääskeläinen, “Nonspecific Diskitis in Children. A Nonmicrobial Disease?,” Clinical Orthopaedics and Related Research 297 (1993): 95–99.

[51] A. H. Crawford, D. Kucharzyk, R. Ruda, and H. Smitherman, “Diskitis in Children,” Clinical Orthopaedics and Related Research 266 (1991): 70–79.

[52] B. R. Jansen, W. Hart, and O. Schreuder, “Discitis in Childhood. 12–35-Year Follow-Up of 35 Patients,” Acta Orthopaedica Scandinavica 64 (1993): 33–36.

[53] J. Chandrasenan, Z. Klezl, R. Bommireddy, and D. Calthorpe, “Spondylodiscitis in Children: A Retrospective Series,” Journal of Bone and Joint Surgery (British Volume) 93 (2011): 1122–1125.

[54] J. M. Henton and H. S. Dabis, “Discitis and Epidural Abscess After Dental Extraction in a Pediatric Patient: A Case Report,” Pediatric Emergency Care 25 (2009): 862–864, https://doi.org/10.1097/PEC.0B013E3181C8C60B.

[55] O. Scheuerman, D. Landau, M. Schwarz, et al., “Cervical Discitis in Children,” Pediatric Infectious Disease Journal 34 (2015): 794–795, https://doi.org/10.1097/INF.0000000000000725.

[56] A. Pizzol, M. Bramuzzo, R. Pillon, A. Taddio, and E. Barbi, “Torticollis as the Presenting Sign of Cervical Spondylodiscitis,” Pediatric Emergency Care 32 (2016): 863–864, https://doi.org/10.1097/PEC.0000000000000643.

[57] H. Waizy, M. Heckel, K. Seller, H. Schroten, and A. Wild, “Remodeling of the Spine in Spondylodiscitis of Children at the Age of 3 Years or Younger,” Archives of Orthopaedic and Trauma Surgery 127 (2007): 403–407, https://doi.org/10.1007/S00402-007-0316-9.

[58] U. A. Kumar, V. M. Sodhai, S. A. Patwardhan, and P. K. Sancheti, “Management of Progressive Unilateral Tibia Vara in a 3-Year-Old Child With Focal Fibrocartilaginous Defect: A Case Report,” JBJS Case Connector 14 (2024): e23, https://doi.org/10.2106/JBJS.CC.23.00593.

[59] M. Fernandez, C. L. Carrol, and C. J. Baker, “Discitis and Vertebral Osteomyelitis in Children: An 18-Year Review,” Pediatrics 105 (2000): 1299–1304.

[60] G. Ananthakrishnan, A. G. Wilkinson, S. F. McGurk, and T. Marshall, “Infantile Chylothorax Associated With Staphylococcal Paravertebral Discitis,” Pediatric Radiology 2009, no. 12 (2009): 1354–1356, https://doi.org/10.1007/S00247-009-1357-8.

[61] S. J. Spencer and N. I. L. Wilson, “Childhood Discitis in a Regional Children's Hospital,” Journal of Pediatric Orthopaedics. Part B 21 (2012): 264–268, https://doi.org/10.1097/BPB.0B013E32834D3E94.

[62] J. Conti, N. Geremia, S. Di Bella, et al., “Infectious Spondylodiscitis: Epidemiology, Diagnosis, Microbiological Findings, Clinical Features and Outcomes in a 14-Year Retrospective Study,” European Journal of Clinical Microbiology & Infectious Diseases 2025, no. 12 (2025): 3067–3078, https://doi.org/10.1007/S10096-025-05292-5.

[63] J. R. Marin, T. W. Lyons, I. Claudius, et al., “Optimizing Advanced Imaging of the Pediatric Patient in the Emergency Department: Technical Report,” Pediatrics 154 (2024): e2024066855, https://doi.org/10.1542/PEDS.2024-066855/197590.

[64] J. P. Dormans and L. Moroz, “Infection and Tumors of the Spine in Children,” Journal of Bone and Joint Surgery (American Volume) 89 (2007): 79–97, https://doi.org/10.2106/JBJS.F.00475.

[65] A. G. Hadjipavlou, J. T. Mader, J. T. Necessary, and A. J. Muffoletto, “Hematogenous Pyogenic Spinal Infections and Their Surgical Management,” Spine 25 (2000): 1668–1679, https://journals.lww.com/spinejournal/Fulltext/2000/07010/Hematogenous_Pyogenic_Spinal_Infections_and_Their.10.aspx.

[66] M. Chargui, A. Krzysztofiak, P. Bernaschi, et al., “Presumptive Bacteriological Diagnosis of Spondylodiscitis in Infants Less Than 4 Years by Detecting K. kingae DNA in Their Oropharynx: Data From a Preliminar Two Centers Study,” Frontiers in Pediatrics 10 (2022): 10, https://doi.org/10.3389/FPED.2022.1046254.

[67] D. Ceroni, W. Belaieff, A. Kanavaki, et al., “Possible Association of Kingella kingae With Infantile Spondylodiscitis,” Pediatric Infectious Disease Journal 32 (2013): 1296–1298.

[68] T. Gouliouris, S. H. Aliyu, and N. M. Brown, “Spondylodiscitis: Update on Diagnosis and Management,” Journal of Antimicrobial Chemotherapy 65 iii (2010): 11–24.

[69] M. Paakkonen, M. J. T. Kallio, P. E. Kallio, and H. Peltola, “Sensitivity of Erythrocyte Sedimentation Rate and C-Reactive Protein in Childhood Bone and Joint Infections,” Clinical Orthopaedics and Related Research 468 (2010): 861–866.

[70] G. Foti, C. Longo, E. Oliboni, et al., “Spondylodiscitis of the Thoraco-Lumbar Spine: Diagnostic Performance of Dual-Energy CT vs. MRI,” European Radiology 35, no. 3 (2024): 1647–1657, https://doi.org/10.1007/S00330-024-11125-4.

[71] F. Maiuri, G. laconetta, B. Gallicchio, A. Manto, and F. Briganti, “Spondylodiscitis: Clinical and Magnetic Resonance Diagnosis,” Spine 22 (1997): 1741–1746.

[72] H. Dahmoush, D. S. Gaddam, M. L. Ho, et al., “ACR Appropriateness Criteria Back Pain-Child: 2024 Update,” Journal of the American College of Radiology 22 (2025): S79–S107, https://doi.org/10.1016/j.jacr.2025.02.037.

[73] A. N. Malani, D. M. Vandenberg, B. Singal, et al., “Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate,” JAMA 309 (2013): 2465–2472, https://doi.org/10.1001/JAMA.2013.6293.

[74] B. C. Dangman, F. A. Hoffer, F. F. Rand, and E. J. O'Rourke, “Osteomyelitis in Children: Gadolinium-Enhanced MR Imaging,” Radiology 182 (1992): 743–747, https://doi.org/10.1148/RADIOLOGY.182.3.1535888.

[75] J. H. Kan, R. S. Young, C. Yu, and M. Hernanz-Schulman, “Clinical Impact of Gadolinium in the MRI Diagnosis of Musculoskeletal Infection in Children,” Pediatric Radiology 40, no. 7 (2010): 1197–1205, https://doi.org/10.1007/S00247-010-1557-2.

[76] L. G. F. Fonseca, M. Garbin, and G. Bertolizio, “Anesthesia for Pediatric Magnetic Resonance Imaging: A Review of Practices and Current Pathways,” Current Opinion in Anaesthesiology 36 (2023): 428–434, https://doi.org/10.1097/ACO.0000000000001267.

[77] K. S. Chan, D. McBride, J. Wild, S. Kwon, J. Samet, and R. F. Gibly, “A Rapid MRI Protocol for the Evaluation of Acute Pediatric Musculoskeletal Infections: Eliminating Contrast and Decreasing Anesthesia, Scan Time, and Hospital Length of Stay and Charges,” Journal of Bone and Joint Surgery 106 (2024): 700–707, https://doi.org/10.2106/JBJS.23.00564.

[78] M. Raghavan and C. J. Palestro, “Imaging of Spondylodiscitis: An Update,” Seminars in Nuclear Medicine 53 (2023): 152–166, https://doi.org/10.1053/J.SEMNUCLMED.2022.11.005.

[79] C. D. Russell, R. Ramaesh, P. Kalima, A. Murray, and M. S. Gaston, “Microbiological Characteristics of Acute Osteoarticular Infections in Children,” Journal of Medical Microbiology 64 (2015): 446–453, https://doi.org/10.1099/jmm.0.000026.

[80] O. Kasalak, M. Wouthuyzen-Bakker, R. A. J. O. Dierckx, P. C. Jutte, and T. C. Kwee, “Time to Reconsider Routine Percutaneous Biopsy in Spondylodiscitis?,” AJNR. American Journal of Neuroradiology 42 (2021): 627–631, https://doi.org/10.3174/ajnr.A6994.

[81] D. G. Malik, M. V. Smith, G. M. Swenson, et al., “Management Outcomes After Image-Guided Percutaneous Biopsy for Suspected Vertebral Osteomyelitis-Discitis,” American Journal of Neuroradiology 46 (2025): 1478–1485, https://doi.org/10.3174/AJNR.A8630.

[82] E. Iwata, M. Scarborough, G. Bowden, M. McNally, Y. Tanaka, and N. A. Athanasou, “The Role of Histology in the Diagnosis of Spondylodiscitis,” Bone & Joint Journal 101 (2019): 246–252, https://doi.org/10.1302/0301-620X.101B3.BJJ-2018-0491.R2/LETTERTOEDITOR.

[83] A. A. Ahmed, S. Y. Park, M. J. Smollin, et al., “Plasma Microbial Cell-Free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal Infections,” Pediatric Infectious Disease Journal 44 (2025): 582–588, https://doi.org/10.1097/INF.0000000000004743.

[84] S. J. Oyeniran, A. L. Leber, and H. Wang, “An In-House Kingella kingae PCR in a Large Pediatric Cohort: Impact on Diagnosis, Antimicrobial Stewardship, and Clinical Outcomes,” Journal of Clinical Microbiology 63 (2025): e00986, https://doi.org/10.1128/JCM.00986-25;WEBSITE:WEBSITE:ASMJ;ISSUE:ISSUE:DOI.

[85] Y. C. Li, Y. X. Liu, L. Li, H. Wang, Z. R. Zhao, and Z. Y. Yao, “Metagenomic Next-Generation Sequencing (mNGS) Versus Tissue Culture Technique (TCT) in Diagnosis of Spinal Infection: A Systematic Review and Meta-Analysis,” Scientific Reports 15, no. 1 (2025): 20926, https://doi.org/10.1038/s41598-025-06759-3.

[86] C. Yin, Y. Cong, H. Wang, et al., “Pathogenic Detection by Metagenomic Next-Generation Sequencing in Spinal Infections,” Spine 50 (2025): 70–75, https://doi.org/10.1097/BRS.0000000000005148.

[87] M. Louie, L. Louie, and A. E. Simor, “The Role of DNA Amplification Technology in the Diagnosis of Infectious Diseases,” Canadian Medical Association Journal 163 (2000): 301–309.

[88] J. García-De-Lomas and D. Navarro, “New Directions in Diagnostics,” Pediatric Infectious Disease Journal 16 (1997): 43–48.

[89] A. E. Budding, M. Hoogewerf, C. M. J. E. Vandenbroucke-Grauls, and P. H. M. Savelkoul, “Automated Broad-Range Molecular Detection of Bacteria in Clinical Samples,” Journal of Clinical Microbiology 54 (2016): 934–943, https://doi.org/10.1128/JCM.02886-15;JOURNAL:JOURNAL:JCM;ISSUE:ISSUE:DOI.

[90] S. K. Rampini, G. V. Bloemberg, P. M. Keller, et al., “Broad-Range 16S rRNA Gene Polymerase Chain Reaction for Diagnosis of Culture-Negative Bacterial Infections,” Clinical Infectious Diseases 53 (2011): 1245–1251, https://doi.org/10.1093/CID/CIR692.

[91] J. Tkadlec, M. Peckova, L. Sramkova, et al., “The Use of Broad-Range Bacterial PCR in the Diagnosis of Infectious Diseases: A Prospective Cohort Study,” Clinical Microbiology and Infection 25 (2019): 747–752, https://doi.org/10.1016/j.cmi.2018.10.001.

[92] O. K. Mahmoud, F. Petri, S. El Zein, et al., “What Is the Accuracy of 16S PCR Followed by Sanger Sequencing or Next-Generation Sequencing in Native Vertebral Osteomyelitis? A Systematic Review and Meta-Analysis,” Clinical Orthopaedics and Related Research 483 (2025): 930–938, https://doi.org/10.1097/CORR.0000000000003314.

[93] A. Both, M. Christner, B. Berinson, et al., “The Added Value of a Commercial 16S/18S-PCR Assay (UMD-SelectNA, Molzym) for Microbiological Diagnosis of Spondylodiscitis: An Observational Study,” in Diagnostic Microbiology and Infectious Disease, vol. 106 (Elsevier Inc., 2023), 106, https://doi.org/10.1016/j.diagmicrobio.2023.115926.

[94] K. Grif, I. Heller, W. M. Prodinger, K. Lechleitner, C. Lass-Flörl, and D. Orth, “Improvement of Detection of Bacterial Pathogens in Normally Sterile Body Sites With a Focus on Orthopedic Samples by Use of a Commercial 16S rRNA Broad-Range PCR and Sequence Analysis,” Journal of Clinical Microbiology 50 (2012): 2250–2254, https://doi.org/10.1128/JCM.00362-12.

[95] D. Sune, H. Rydberg, Å. N. Augustinsson, L. Serrander, and M. B. Jungeström, “Optimization of 16S rRNA Gene Analysis for Use in the Diagnostic Clinical Microbiology Service,” Journal of Microbiological Methods 170 (2020): 105854, https://doi.org/10.1016/J.MIMET.2020.105854.

[96] A. Lieu, L. B. Harrison, J. Harel, A. Lawandi, M. P. Cheng, and M. C. Domingo, “The Microbiological Outcomes of Culture-Negative Blood Specimens Using 16S rRNA Broad-Range PCR Sequencing: A Retrospective Study in a Canadian Province From 2018 to 2022,” Journal of Clinical Microbiology 62 (2024): e01518, https://doi.org/10.1128/JCM.01518-23.

[97] Ø. Kommedal, K. Lekang, N. Langeland, and H. G. Wiker, “Characterization of Polybacterial Clinical Samples Using a Set of Group-Specific Broad-Range Primers Targeting the 16S rRNA Gene Followed by DNA Sequencing and RipSeq Analysis,” Journal of Medical Microbiology 60 (2011): 927–936, https://doi.org/10.1099/JMM.0.028373-0/CITE/REFWORKS.

[98] G. De Marco, B. Cochard, G. Di Laura Frattura, S. Valisena, L. Bazin, and D. Ceroni, “Reflection on Osteoarticular Infections in Children,” Frontiers in Pediatrics 11 (2023): 1280878, https://doi.org/10.3389/fped.2023.1280878.

[99] A. D. Chiang and J. P. Dekker, “From the Pipeline to the Bedside: Advances and Challenges in Clinical Metagenomics,” Journal of Infectious Diseases 221 (2020): S331–S340, https://doi.org/10.1093/INFDIS/JIZ151.

[100] A. S. Morel, G. Dubourg, E. Prudent, et al., “Complementarity Between Targeted Real-Time Specific PCR and Conventional Broad-Range 16S rDNA PCR in the Syndrome-Driven Diagnosis of Infectious Diseases,” European Journal of Clinical Microbiology & Infectious Diseases 34, no. 3 (2014): 561–570, https://doi.org/10.1007/S10096-014-2263-Z.

[101] J. B. Searns, C. C. Robinson, Q. Wei, et al., “Validation of a Novel Molecular Diagnostic Panel for Pediatric Musculoskeletal Infections: Integration of the Cepheid Xpert MRSA/SA SSTI and Laboratory-Developed Real-Time PCR Assays for Clindamycin Resistance Genes and Kingella kingae Detection,” Journal of Microbiological Methods 156 (2019): 60–67, https://doi.org/10.1016/J.MIMET.2018.12.004.

[102] E. Navarro, G. Serrano-Heras, M. J. Castaño, and J. Solera, “Real-Time PCR Detection Chemistry,” Clinica Chimica Acta 439 (2015): 231–250, https://doi.org/10.1016/J.CCA.2014.10.017.

[103] N. El Houmami, G. A. Durand, J. Bzdrenga, et al., “A New Highly Sensitive and Specific Real-Time PCR Assay Targeting the Malate Dehydrogenase Gene of Kingella kingae and Application to 201 Pediatric Clinical Specimens,” Journal of Clinical Microbiology 56 (2018): 10–128, https://doi.org/10.1128/jcm.00505-18.

[104] P. Lehours, A. M. Freydière, O. Richer, et al., “The rtxA Toxin Gene of Kingella kingae: A Pertinent Target for Molecular Diagnosis of Osteoarticular Infections,” Journal of Clinical Microbiology 49 (2011): 1245–1250, https://doi.org/10.1128/JCM.01657-10.

[105] V. E. de Knegt, G. Q. Kristiansen, and K. Schønning, “Evaluation of Dual Target-Specific Real-Time PCR for the Detection of Kingella kingae in a Danish Paediatric Population,” Infectious Diseases 50 (2018): 200–206, https://doi.org/10.1080/23744235.2017.1376254.

[106] D. Ceroni, A. Cherkaoui, S. Ferey, A. Kaelin, and J. Schrenzel, “Kingella kingae Osteoarticular Infections in Young Children: Clinical Features and Contribution of a New Specific Real-Time PCR Assay to the Diagnosis,” Journal of Pediatric Orthopedics 30 (2010): 301–304.

[107] S. Chometon, Y. Benito, M. Chaker, et al., “Specific Real-Time Polymerase Chain Reaction Places Kingella kingae as the Most Common Cause of Osteoarticular Infections in Young Children,” Pediatric Infectious Disease Journal 26 (2007): 377–381.

[108] A. Cherkaoui, D. Ceroni, S. Emonet, Y. Lefevre, and J. Schrenzel, “Molecular Diagnosis of Kingella kingae Osteoarticular Infections by Specific Real-Time PCR Assay,” Journal of Medical Microbiology 58 (2009): 65–68.

[109] W. Yan, “Multiplex PCR Primer Design for Simultaneous Detection of Multiple Pathogens,” in Methods in Molecular Biology, vol. 1275 (Humana Press Inc., 2015), 91–101, https://doi.org/10.1007/978-1-4939-2365-6_6/FIGURES/5.

[110] L. Burgart, R. Robinson, M. Heller, W. Wilke, O. Iakoubova, and J. Cheville, “Multiplex Polymerase Chain Reaction,” Modern Pathology 3 (1992): 320–323.

[111] J. M. Miller, M. J. Binnicker, S. Campbell, et al., “A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology,” Clinical Infectious Diseases 67 (2018): e1–e94, https://doi.org/10.1093/cid/ciy381.

[112] M. B. Pasticci, S. Bozza, G. V. De Socio, A. Frias-Mazuecos, and A. Mencacci, “Improving the Etiological Diagnosis of Osteoarticular Infections With the Commercial Multiplex Real-Time Polymerase Chain Reaction SeptiFast,” Diagnostic Microbiology and Infectious Disease 97 (2020): 115002, https://doi.org/10.1016/J.DIAGMICROBIO.2020.115002.

[113] Y. Wang, W. Xia, Y. Wang, et al., “Multiplexed Bacterial Pathogen Detection and Clinical Characteristics of Orthopedic Infection in Hospitalized Patients,” Frontiers in Cellular and Infection Microbiology 14 (2024): 1394352, https://doi.org/10.3389/FCIMB.2024.1394352/BIBTEX.

[114] L. Salar-Vidal, C. Chaves, I. T. Dianzo-Delgado, et al., “Multicenter Evaluation of BioFire JI Panel Related to Improved Microbiological Diagnostics on Acute Osteoarticular Infections,” International Journal of Medical Microbiology 313 (2023): 151588, https://doi.org/10.1016/J.IJMM.2023.151588.

[115] B. C. Sanchez, H. Sayeed, D. T. Niles, and J. J. Dunn, “Clinical Performance of a Syndromic Panel for Direct Identification of Pathogens and Antimicrobial Resistance Markers in Pediatric Osteoarticular and Pleural Space Infections,” Journal of Clinical Microbiology 63 (2025): e00621, https://doi.org/10.1128/JCM.00621-25.

[116] C. R. Woods, J. S. Bradley, A. Chatterjee, et al., “Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics,” Journal of the Pediatric Infectious Diseases Society 13 (2024): 1–59, https://doi.org/10.1093/jpids/piad089.

[117] M. Gupton and J. Burns, “Metagenomic Next-Generation Sequencing in Osteoarticular Infections With a Focus on Pediatrics: Current Concepts and Clinical Applications,” EFORT Open Reviews 8 (2023): 199–212, https://doi.org/10.1530/EOR-22-0136.

[118] N. Ramchandar, N. G. Coufal, A. S. Warden, et al., “Metagenomic Next-Generation Sequencing for Pathogen Detection and Transcriptomic Analysis in Pediatric Central Nervous System Infections,” Open Forum Infectious Diseases 8 (2021): ofab104, https://doi.org/10.1093/OFID/OFAB104.

[119] C. Ma, H. Wu, G. Chen, C. Liang, L. Wu, and Y. Xiao, “The Potential of Metagenomic Next-Generation Sequencing in Diagnosis of Spinal Infection: A Retrospective Study,” European Spine Journal 31 (2022): 442–447, https://doi.org/10.1007/s00586-021-07026-5.

[120] P. J. Simner, S. Miller, and K. C. Carroll, “Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases,” Clinical Infectious Diseases 66 (2018): 778–788, https://doi.org/10.1093/CID/CIX881.

[121] K. N. Govender, T. L. Street, N. D. Sanderson, and D. W. Eyre, “Metagenomic Sequencing as a Pathogen-Agnostic Clinical Diagnostic Tool for Infectious Diseases: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies,” Journal of Clinical Microbiology 59 (2021): 10–128, https://doi.org/10.1128/JCM.02916-20.

[122] W. Gu, S. Miller, and C. Y. Chiu, “Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection,” Annual Review of Pathology: Mechanisms of Disease 14 (2019): 319–338, https://doi.org/10.1146/annurev-pathmechdis-012418-012751.

[123] C. Y. Chiu and S. A. Miller, “Clinical Metagenomics,” Nature Reviews Genetics 20, no. 6 (2019): 341–355, https://doi.org/10.1038/s41576-019-0113-7.

[124] L. M. Filkins, A. L. Bryson, S. A. Miller, and S. L. Mitchell, “Navigating Clinical Utilization of Direct-From-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations,” Clinical Chemistry 66 (2020): 1381–1395, https://doi.org/10.1093/CLINCHEM/HVAA183.

[125] S. Goodwin, J. D. McPherson, and W. R. McCombie, “Coming of Age: Ten Years of Next-Generation Sequencing Technologies,” Nature Reviews Genetics 17, no. 6 (2016): 333–351, https://doi.org/10.1038/nrg.2016.49.

[126] S. J. Salipante, D. J. SenGupta, L. A. Cummings, T. A. Land, D. R. Hoogestraat, and B. T. Cookson, “Application of Whole-Genome Sequencing for Bacterial Strain Typing in Molecular Epidemiology,” Journal of Clinical Microbiology 53 (2015): 1072–1079, https://doi.org/10.1128/JCM.03385-14.

[127] L. A. Cummings, K. Kurosawa, D. R. Hoogestraat, et al., “Clinical Next Generation Sequencing Outperforms Standard Microbiological Culture for Characterizing Polymicrobial Samples,” Clinical Chemistry 62 (2016): 1465–1473, https://doi.org/10.1373/CLINCHEM.2016.258806.

[128] S. Somasekar, D. Lee, J. Rule, et al., “Viral Surveillance in Serum Samples From Patients With Acute Liver Failure by Metagenomic Next-Generation Sequencing,” Clinical Infectious Diseases 65 (2017): 1477–1485, https://doi.org/10.1093/cid/cix596.

[129] M. K. Sahoo, M. I. Lefterova, F. Yamamoto, et al., “Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing,” Journal of Clinical Microbiology 51 (2013): 3700–3710, https://doi.org/10.1128/JCM.01605-13.

[130] M. J. Ellington, O. Ekelund, F. M. Aarestrup, et al., “The Role of Whole Genome Sequencing in Antimicrobial Susceptibility Testing of Bacteria: Report From the EUCAST Subcommittee,” Clinical Microbiology and Infection 23 (2017): 2–22, https://doi.org/10.1016/J.CMI.2016.11.012.

[131] L. Lüftinger, I. Ferreira, B. J. H. Frank, et al., “Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and Limitations,” Biomedicine 9 (2021): 910, https://doi.org/10.3390/BIOMEDICINES9080910.

[132] R. Schlaberg, C. Y. Chiu, S. Miller, G. W. Procop, and G. Weinstock, “Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection,” Archives of Pathology & Laboratory Medicine 141 (2017): 776–786, https://doi.org/10.5858/ARPA.2016-0539-RA.

[133] P. Edward and A. S. Handel, “Metagenomic Next-Generation Sequencing for Infectious Disease Diagnosis: A Review of the Literature With a Focus on Pediatrics,” Journal of the Pediatric Infectious Diseases Society 10 (2021): 71–77, https://doi.org/10.1093/JPIDS/PIAB104.

[134] T. A. Blauwkamp, S. Thair, M. J. Rosen, et al., “Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease,” Nature Microbiology 4 (2019): 663–674, https://doi.org/10.1038/s41564-018-0349-6.

[135] P. Yagupsky, “The Past, Present, and Future of Kingella kingae Detection in Pediatric Osteoarthritis,” Diagnostics 12, no. 12 (2022): 2932, https://doi.org/10.3390/DIAGNOSTICS12122932.

[136] D. Ceroni, V. Dubois-Ferriere, A. Cherkaoui, et al., “Detection of Kingella kingae Osteoarticular Infections in Children by Oropharyngeal Swab PCR,” Pediatrics 31 (2013): 230–235, https://doi.org/10.1542/peds.2012-0810.

RIGHTS & PERMISSIONS

2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.